Literature DB >> 18798120

Chromoblastomycosis caused by a meristematic mutant of Fonsecaea monophora.

Liyan Xi1, Changming Lu, Jiufeng Sun, Xiqing Li, Honfang Liu, Junmin Zhang, Zhi Xie, G S De Hoog.   

Abstract

We report the first case of chromoblastomycosis caused by a meristematic mutant of Fonsecaea monophora in an 81-year-old Cantonese male. The patient had a seven-month history of a red plaque with thick yellow crust and purulent exudates on the back of his right hand. Microscopic examination of direct smears revealed brown sclerotic cells and black colonies were recovered in culture from samples of the purulent exudantes. The microscopic appearance of this isolate was quite different from that of other Fonsecaea species, exhibiting mere meristematic growth. The rDNA ITS sequence data confirmed that this isolate was a mutant of Fonsecaea monophora. The patient showed good response to treatment with itraconazole and complete healing was achieved without relapse after long-term follow-up.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18798120     DOI: 10.1080/13693780802322588

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  10 in total

1.  Molecular cloning, characterization and differential expression of Cdc42 in Fonsecaea monophora.

Authors:  Zhi Xie; Peiying Feng; Junming Zhang; Xiqing Li; Jiufeng Sun; Changming Lu; Huaiqiu Huang; Liyan Xi
Journal:  Mol Biol Rep       Date:  2011-05-15       Impact factor: 2.316

2.  Melanin in a meristematic mutant of Fonsecaea monophora inhibits the production of nitric oxide and Th1 cytokines of murine macrophages.

Authors:  Junmin Zhang; Li Wang; Liyan Xi; Huaiqiu Huang; Yongxuan Hu; Xiqing Li; Xiao Huang; Sha Lu; Jiufeng Sun
Journal:  Mycopathologia       Date:  2012-10-03       Impact factor: 2.574

3.  Melanization of a meristematic mutant of Fonsecaea monophora increases tolerance to stress factors while no effects on antifungal susceptibility.

Authors:  Jiufeng Sun; Junmin Zhang; M J Najafzadeh; Hamid Badali; Xiqing Li; Liyan Xi; G S de Hoog
Journal:  Mycopathologia       Date:  2011-06-26       Impact factor: 2.574

Review 4.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

5.  Pathogenicity and Growth Conditions Modulate Fonsecaea Extracellular Vesicles' Ability to Interact With Macrophages.

Authors:  Lucas de Oliveira Las-Casas; Clara Luna Freitas Marina; Raffael Júnio Araújo de Castro; Luísa Coutinho Coelho; Sônia Nair Báo; G Sybren de Hoog; Vânia Aparecida Vicente; Larissa Fernandes; Anamelia Lorenzetti Bocca
Journal:  Front Cell Infect Microbiol       Date:  2022-06-09       Impact factor: 6.073

6.  Murine model of a disseminated infection by the novel fungus Fonsecaea monophora and successful treatment with posaconazole.

Authors:  Enrique Calvo; F Javier Pastor; M Mar Rodríguez; Emilio Mayayo; Valentina Salas; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

Review 7.  Challenges in the therapy of chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Daniel Wagner de C L Santos
Journal:  Mycopathologia       Date:  2013-05-02       Impact factor: 2.574

Review 8.  Chromoblastomycosis in Mainland China: a systematic review on clinical characteristics.

Authors:  Sha Lu; Changming Lu; Junmin Zhang; Yongxuan Hu; Xiqing Li; Liyan Xi
Journal:  Mycopathologia       Date:  2012-10-20       Impact factor: 2.574

Review 9.  Chromoblastomycosis.

Authors:  Paweł M Krzyściak; Małgorzata Pindycka-Piaszczyńska; Michał Piaszczyński
Journal:  Postepy Dermatol Alergol       Date:  2014-10-22       Impact factor: 1.837

10.  The role of melanin pathways in extremotolerance and virulence of Fonsecaea revealed by de novo assembly transcriptomics using illumina paired-end sequencing.

Authors:  X Q Li; B L Guo; W Y Cai; J M Zhang; H Q Huang; P Zhan; L Y Xi; V A Vicente; B Stielow; J F Sun; G S de Hoog
Journal:  Stud Mycol       Date:  2016-02-28       Impact factor: 16.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.